CompletedNot Applicable

Sleep Characteristics in Post-COVID-19 Patients

Germany31 participantsStarted 2021-11-25

Plain-language summary

After acute infection, patients with coronavirus disease 2019 (COVID-19) often suffer from persisting symptoms for more than 3 months (post COVID-19). Sleep disorders (31%) have already been assessed by questionnaires and interviews in post-COVID-19, but have not yet been proven by polysomnography (PSG), the gold standard for sleep testing. This study aimed to measure sleep characteristics in post-COVID-19 patients.

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Post-COVID-19 Group: * Patients after SARS-CoV-2 infection with signs of Post-COVID-19 * ≥18 years * written informed consent Healthy controls: * No history of SARS-CoV-2 infection * ≥18 years * written informed consent Exclusion Criteria: Post-COVID-19 Group: * Diagnosis of a breathing-related sleep disorder before SARS-CoV-2 infection * BMI \>25kg/m2 Healthy controls: * Diagnosis of a breathing-related sleep disorder * BMI \>25kg/m2

What they're measuring

Apnea-Hypopnea-Index (AHI)

Timeframe: One single night on study day 4

Trial details

NCT IDNCT05124548

SponsorSchön Klinik Berchtesgadener Land

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-11-28

View on ClinicalTrials.gov More Post-COVID-19 trials